QUANTIFICATION OF CSF VELOCITY THROUGH THE NARROWEST POINT IN AQUEDUCT OF SYLVIA FOR NORMAL AND NORMAL PRESSURE HYDROCEPHALUS PATIENT BY CFD ANALYSIS

Abstract

The aim of this comprehensive study is to quantify the velocity variation of cerebrospinal fluid (CSF) for narrowest point in aqueduct of Sylvia (AqSylv) of normal patients and normal pressure hydrocephalus (NPH) patient by corresponds to its concave shapes of anteriorly and inferiorly. T1-weighted 3-T magnetic resonance images (MRI) of the head in DICOM (Digital Imaging and Communications in Medicine) format were taken from three controlled patients whose were admitted to Thammasat Hospital, Thailand. Patients were 29 to 52 y of age with two normal patients and one (NPH) patient. DICOM files were three-dimensionally reconstructed by using 3D slicer software, and geometric information of an aqueduct for all three cases was noted. Solid models of the aqueduct for both normal patient and NPH condition were developed based on the geometric information. Computational fluid dynamics (CFD) were analyzed to quantify the CSF velocity variation throughout the narrowest point of the aqueduct for both cases, i.e. normal and NPH condition. Retrospective results of “mathematical model for dynamics of CSF through the aqueduct of Sylvia based on an analogy of arterial dilation and contraction” were used as initial data for ANSYS CFX analysis. The results showed the CSF flow through the aqueduct in a pulsatile pattern in both cases. At the narrowest point of the aqueduct, amplitude of peak CSF velocity for NPH patients was significantly higher than that of normal patient. CSF velocity variation throughout the aqueduct co-relates with the pressure gradient inside the aqueduct and increased in the third ventricle direction.

Authors and Affiliations

Thalakotunage A. H, Thunyaseth Sethaput

Keywords

Related Articles

MOLECULAR ANALYSIS OF THE CAMP- RESPONSE ELEMENT [CRE] ELEMENTS IN THE PROMOTER REGION AND EXON 1 OF THE SURVIVAL OF MOTOR NEURON 2 [SMN2] GENE IN MALAYSIAN SPINAL MUSCULAR ATROPHY PATIENTS; TO ELUCIDATE THEIR ROLE IN CIRCUMSCRIBING THE CLINICAL SEVERITY

Objective: In the Spinal muscular atrophy [SMA] genes [SMN1 and SMN2 genes]; the CRE-II elements at -400 bp in the promoter region of the SMN genes and CRE-I element at +108 bp in the exon 1 of the SMN genes, are reporte...

CYTOTOXICITY STUDIES OF TETRAPRELYLTOLUQUINONE, A PRENILATED HYDROQUINONE FROM GARCINA COWA ROXB ON H-460, MCF-7 AND DU-145

Objective: The aim of the present study was to examine the cytotoxicity of a new ring-reduced tetra prenyltoluquinone (TPTQ), [2E,6E,10E]-(+)-4b-hydroxy-3-methyl-5b-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl-2-cy...

MESOIONIC SYDNONE: A REVIEW IN THEIR CHEMICAL AND BIOLOGICAL PROPERTIES

Various literature sources have documented sydnones as important molecules with exclusive chemical properties and a wide spectrum of bioactivities. Sydnone can be defined as a five-membered pseudo-aromatic heterocyclic m...

APPLICATION OF MODIFIED USP APPARATUS I AND IN SITU FIBER OPTIC ANALYSIS FOR DRUG RELEASE FROM IBUPROFEN NANOSPHERES

Objective: The main objective of this study was to ascertain the applicability of the modified USP Apparatus I and in situ fiber optic UV analysis for in vitro release testing of ibuprofen (model drug) nanospheres (IbNS)...

QUANTIFICATION OF URAPIDIL IN HUMAN PLASMA USING ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY–ELECTROSPRAY IONIZATION MASS SPECTROMETRY (UPLC–MS/MS) FOR PHARMACOKINETIC STUDY IN HEALTHY INDIAN VOLUNTEERS

Objective: A rapid and selective quantitative method was developed and validated in human plasma for urapidil pharmacokinetic study in healthy Indian volunteers.Methods: The ultra-performance liquid chromatography–tand...

Download PDF file
  • EP ID EP575984
  • DOI 10.22159/ijpps.2016v8s2.15222
  • Views 68
  • Downloads 0

How To Cite

Thalakotunage A. H, Thunyaseth Sethaput (2016). QUANTIFICATION OF CSF VELOCITY THROUGH THE NARROWEST POINT IN AQUEDUCT OF SYLVIA FOR NORMAL AND NORMAL PRESSURE HYDROCEPHALUS PATIENT BY CFD ANALYSIS. International Journal of Pharmacy and Pharmaceutical Sciences, 8(2), 52-55. https://europub.co.uk/articles/-A-575984